Targeting angiogenesis for treatment of NSCLC brain metastases.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Cancer Drug Targets

• Publication date

  2012-02-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156800912799277476PMID 22229249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases

  2011cited by this paper
• EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor.

  2011cited by this paper
• Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.

  2011cited by this paper
• Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

  2010cited by this paper
• O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.

  2010cited by this paper
• Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

  2010cited by this paper
• Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis

  2010cited by this paper
• Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma.

  2010cited by this paper
• Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.

  2010cited by this paper
• AACR centennial series: the biology of cancer metastasis: historical perspective.

  2010cited by this paper
• The Expression of Three Genes in Primary Non–Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain

  2009cited by this paper
• Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases.

  2009cited by this paper
• The Vascular Basement Membrane as “Soil” in Brain Metastasis

  2009cited by this paper
• Bevacizumab Safety in Patients with Central Nervous System Metastases

  2009cited by this paper
• Differential Expression of Biomarkers in Primary Non-small Cell Lung Cancer and Metastatic Sites

  2009cited by this paper
• Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.

  2009cited by this paper
• WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

  2009cited by this paper
• Systemic therapy for lung cancer brain metastases: a rationale for clinical trials.

  2008cited by this paper
• Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

  2008cited by this paper
• Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability.

  2008cited by this paper
• An experimental model of brain metastasis of lung carcinoma

  2008cited by this paper
• HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.

  2008cited by this paper
• Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.

  2008cited by this paper
• Mechanisms of adverse effects of anti-VEGF therapy for cancer

  2007cited by this paper
• Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis.

  2007cited by this paper
• CNS Metastasis: An Old Problem in a New Guise

  2007cited by this paper
• Contribution of Carrier-Mediated Transport Systems to the Blood–Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development

  2007cited by this paper
• Multidisciplinary management of brain metastases.

  2007cited by this paper
• Matrix metalloproteinases and the regulation of tissue remodelling

  2007cited by this paper
• Targeting multidrug resistance in cancer

  2006cited by this paper
• Activation of stat3 in human melanoma promotes brain metastasis.

  2006cited by this paper
• Integrin Regulation by Vascular Endothelial Growth Factor in Human Brain Microvascular Endothelial Cells

  2006cited by this paper
• Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

  2006cited by this paper
• AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.

  2005cited by this paper
• Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

  2005cited by this paper
• Brain Metastases from Hepatocellular Carcinoma in US Patients

  2005cited by this paper
• Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease.

  2005cited by this paper
• N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling.

  2004cited by this paper
• Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

  2004cited by this paper
• Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice

  2004cited by this paper
• Management of brain metastases.

  2004cited by this paper
• Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice

  2004cited by this paper
• Regulation of cell function by extracellular matrix

  2004cited by this paper
• Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

  2004cited by this paper
• In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

  2003cited by this paper
• The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

  2003cited by this paper
• Vascular Endothelial Growth Factor Regulates Focal Adhesion Assembly in Human Brain Microvascular Endothelial Cells through Activation of the Focal Adhesion Kinase and Related Adhesion Focal Tyrosine Kinase*

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Angiogenesis: Tumorigenesis and the angiogenic switch

  2003cited by this paper
• The seed and soil hypothesis: vascularisation and brain metastases.

  2002cited by this paper
• Adhesion events in angiogenesis.

  2001cited by this paper
• Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.

  2001cited by this paper
• Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.

  2001cited by this paper
• Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes.

  2000cited by this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

  2000cited by this paper
• Vascular Endothelial Growth Factor Up-regulates ICAM-1 Expression via the Phosphatidylinositol 3 OH-kinase/AKT/Nitric Oxide Pathway and Modulates Migration of Brain Microvascular Endothelial Cells*

  2000cited by this paper
• Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

  1997cited by this paper
• Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung

  1997cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

  1991cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect.

  1987cited by this paper

• Research progress of anti-angiogenic therapy combined with immunotherapy and radiotherapy for the treatment of brain metastases in non-small cell lung cancer (Review)

  2025cites this paper
• Long noncoding RNA LGALS8-AS1 promotes angiogenesis and brain metastases in non-small cell lung cancer.

  2023cites this paper
• The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy

  2021cites this paper
• Research Progress and Challenges in the Treatment of Central Nervous System Metastasis of Non-Small Cell Lung Cancer

  2021cites this paper
• Effect of Recombinant Human Endostatin Injection Combined with Chemotherapy on Non-Small Cell Lung Cancer and Activated Circulating Endothelial Cells

  2021cites this paper
• Histopathologic analysis of brain metastasis in pulmonary adenocarcinoma: Necrosis is a new risk factor.

  2019cites this paper
• Real world study of regimen containing bevacizumab as first‐line therapy in Chinese patients with advanced non‐small cell lung cancer

  2018cites this paper
• An Investigation into the potential anti-cancer activities of an extract from a Himalayan fungus

  2018cites this paper
• Effect of erlotinib plus bevacizumab on brain metastases in patients with non-small cell lung cancer.

  2018cites this paper
• La synthèse de NETs par les angiopoïétines -1 et -2 contribue à des activités pro-inflammatoires et pro-angiogéniques

  2018cites this paper
• Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE)

  2017cites this paper
• DCEMRI IN BRAIN TUMOR DIAGNOSIS

  2017cites this paper
• Systemic treatment of non-small cell lung cancer brain metastases

  2016influential citation
• A Meta-analysis evaluating stereotactic radiotherapy combined with WBRT versus SRT alone for the NSCLC patients with brain metastases

  2016cites this paper
• Identification of Potential Anticancer Activities of Novel Ganoderma lucidum Extracts Using Gene Expression and Pathway Network Analysis

  2016cites this paper
• Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer

  2016cites this paper
• First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices

  2016cites this paper
• Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer.

  2016cites this paper
• Lung Cancer Cellular Apoptosis Induced by Recombinant Human Endostatin Gold Nanoshell‐Mediated Near‐Infrared Thermal Therapy

  2015cites this paper
• Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers

  2015cites this paper
• Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria)

  2014influential citation
• Update on the use of angiogenesis inhibitors in adult patients with brain tumors.

  2014cites this paper
• Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours

  2013cites this paper
• Brain Neoplasms and Coagulation

  2013cites this paper
• Update on bevacizumab and other angiogenesis inhibitors for brain cancer

  2013cites this paper
• Targeted therapy for brain metastases.

  2012cites this paper